GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
2022-03-07 $0.710 $0.710 $0.670 $0.680 214 200
2022-03-04 $0.720 $0.720 $0.680 $0.700 156 100
2022-03-03 $0.720 $0.740 $0.700 $0.720 117 600
2022-03-02 $0.720 $0.740 $0.690 $0.720 174 800
2022-03-01 $0.700 $0.730 $0.700 $0.710 108 700
2022-02-28 $0.720 $0.740 $0.700 $0.700 83 000
2022-02-25 $0.710 $0.740 $0.700 $0.730 168 600
2022-02-24 $0.690 $0.730 $0.680 $0.720 321 300
2022-02-23 $0.740 $0.750 $0.700 $0.720 216 500
2022-02-22 $0.730 $0.780 $0.710 $0.760 314 500
2022-02-18 $0.760 $0.770 $0.740 $0.770 177 600
2022-02-17 $0.780 $0.780 $0.750 $0.770 181 500
2022-02-16 $0.770 $0.790 $0.750 $0.770 86 900
2022-02-15 $0.760 $0.80 $0.750 $0.780 77 400
2022-02-14 $0.750 $0.81 $0.750 $0.760 176 400
2022-02-11 $0.780 $0.80 $0.750 $0.750 169 900
2022-02-10 $0.81 $0.81 $0.770 $0.790 131 500
2022-02-09 $0.80 $0.82 $0.770 $0.790 281 200
2022-02-08 $0.760 $0.770 $0.740 $0.770 77 600
2022-02-07 $0.740 $0.780 $0.730 $0.760 144 600
2022-02-04 $0.730 $0.750 $0.730 $0.750 188 000
2022-02-03 $0.750 $0.760 $0.730 $0.730 79 500
2022-02-02 $0.780 $0.790 $0.750 $0.760 219 400
2022-02-01 $0.770 $0.80 $0.760 $0.780 220 500
2022-01-31 $0.720 $0.80 $0.720 $0.770 360 100
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT